Physician profile
Derek Miles
NPI 1407887391
$8,029.90
in general payments reported to CMS, 2019-2025
23 companies · $1,596 in 2025
The $1,596 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $564 · 2021: $506 · 2022: $1,281 · 2023: $1,184 · 2024: $2,478 · 2025: $1,596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,308 · Travel and Lodging: $761 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,307.50 |
| Travel and Lodging | $760.96 |
| Education | $189.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,711.57 | 2023-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $1,313.89 | 2019-2025 | Erleada, Akeega, Balversa |
| Medtronic, INC. | $917.83 | 2021-2025 | Interstim |
| Procept Biorobotics Corporation | $570.80 | 2022-2025 | Aquabeam System |
| Boston Scientific Corporation | $341.90 | 2019-2025 | Lumenis Pulse 120h, Rezum Generator, Ams 800 Artificial Urinary Sphincter |
| Pfizer INC. | $332.57 | 2019-2025 | |
| Coloplast Corp | $257.09 | 2025 | |
| Astellas Pharma US INC | $223.49 | 2020-2025 | Xtandi |
| Dornier Medtech America, INC | $208.04 | 2020 | |
| Medtronic USA, INC. | $200.38 | 2019-2020 | |
| Tolmar, INC. | $199.10 | 2023-2025 | |
| Axonics, INC. | $185.80 | 2022-2023 | Axonics |
| Inari Medical, INC. | $159.41 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Endo Pharmaceuticals INC. | $117.37 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $86.60 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $53.07 | 2021-2024 | Prolaris |
| Cumberland Pharmaceuticals, INC. | $51.54 | 2022 | |
| Kerecis Limited | $31.23 | 2021 | |
| Cook Medical LLC | $18.11 | 2020 | |
| Merck Sharp & Dohme LLC | $14.42 | 2021 | |
| Smith+Nephew, INC. | $14.21 | 2019 | |
| Photocure INC | $12.94 | 2022 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.